LDL-C target achievement after adding evinacumab in 2 patients with autosomal recessive hypercholesterolemia
These cases demonstrate a marked and clinically meaningful LDL-C-lowering effect of evinacumab in ARH, supporting its use as an effective LDL-R-independent therapeutic option.
Authors
- Giuliana Mombelli (ORCID: https://orcid.org/0000-0003-2886-134X)
- Francesco Vicari
- Antonia Alberti
- Cesare Riccardo Sirtori
- Chiara Moschetti
- Laura Calabresi
Institutions
- AOL (United States) (US)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jacl.2026.02.007
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00